日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

ANP32 proteins from ticks and vertebrates are key host factors for replication of Bourbon virus across species.

来自蜱虫和脊椎动物的 ANP32 蛋白是波旁病毒跨物种复制的关键宿主因子

Zhang Zhenyu, Aziati Ishmael D, Nipper Thomas, Boon Adrianus C M, Mehle Andrew

Serosurveillance and the first detection of Bourbon virus RNA in a wildlife host

血清监测和在野生动物宿主中首次检测到波旁病毒 RNA

Gayan Bamunuarachchi, Fernando Najera, Ishmael D Aziati, Jamie L Palmer, Elizabeth G Biro, Dave Wang, Sharon L Deem, Adrianus C M Boon, Solny A Adalsteinsson

Prevalence of Bourbon and Heartland viruses in field collected ticks at an environmental field station in St. Louis County, Missouri, USA

美国密苏里州圣路易斯县某环境野外站采集的蜱虫中波旁病毒和哈特兰病毒的流行情况

Aziati, Ishmael D; Jnr, Derek McFarland; Antia, Avan; Joshi, Astha; Aviles-Gamboa, Anahi; Lee, Preston; Harastani, Houda; Wang, David; Adalsteinsson, Solny A; Boon, Adrianus C M

A potently neutralizing SARS-CoV-2 antibody inhibits variants of concern by utilizing unique binding residues in a highly conserved epitope

一种强效中和 SARS-CoV-2 抗体利用高度保守的表位中的独特结合残基来抑制令人关注的变异株

Laura A VanBlargan, Lucas J Adams, Zhuoming Liu, Rita E Chen, Pavlo Gilchuk, Saravanan Raju, Brittany K Smith, Haiyan Zhao, James Brett Case, Emma S Winkler, Bradley M Whitener, Lindsay Droit, Ishmael D Aziati, Traci L Bricker, Astha Joshi, Pei-Yong Shi, Adrian Creanga, Amarendra Pegu, Scott A Handl

A vaccine-induced public antibody protects against SARS-CoV-2 and emerging variants

疫苗诱导产生的公众抗体可抵御SARS-CoV-2及其新出现的变种病毒。

Aaron J Schmitz ,Jackson S Turner ,Zhuoming Liu ,Julian Q Zhou ,Ishmael D Aziati ,Rita E Chen ,Astha Joshi ,Traci L Bricker ,Tamarand L Darling ,Daniel C Adelsberg ,Clara G Altomare ,Wafaa B Alsoussi ,James Brett Case ,Laura A VanBlargan ,Tingting Lei ,Mahima Thapa ,Fatima Amanat ,Trushar Jeevan ,Thomas Fabrizio ,Jane A O'Halloran ,Pei-Yong Shi ,Rachel M Presti ,Richard J Webby ,Florian Krammer ,Sean P J Whelan ,Goran Bajic ,Michael S Diamond ,Adrianus C M Boon ,Ali H Ellebedy

A public vaccine-induced human antibody protects against SARS-CoV-2 and emerging variants

公共疫苗诱导的人类抗体可预防 SARS-CoV-2 及其新出现的变体

Aaron J Schmitz, Jackson S Turner, Zhuoming Liu, Ishmael D Aziati, Rita E Chen, Astha Joshi, Traci L Bricker, Tamarand L Darling, Daniel C Adelsberg, Wafaa B Alsoussi, James Brett Case, Tingting Lei, Mahima Thapa, Fatima Amanat, Jane A O'Halloran, Pei-Yong Shi, Rachel M Presti, Florian Krammer, Gora

A potently neutralizing anti-SARS-CoV-2 antibody inhibits variants of concern by binding a highly conserved epitope

一种强效中和抗SARS-CoV-2抗体通过结合高度保守的表位来抑制令人担忧的变异株。

VanBlargan, Laura; Adams, Lucas; Liu, Zhuoming; Chen, Rita E; Gilchuk, Pavlo; Raju, Saravanan; Smith, Brittany; Zhao, Haiyan; Case, James Brett; Winkler, Emma S; Whitener, Bradley; Droit, Lindsay; Aziati, Ismael; Shi, Pei-Yong; Creanga, Adrian; Pegu, Amarendra; Handley, Scott; Wang, David; Boon, Adrianus; Crowe, James E; Whelan, Sean P J; Fremont, Daved; Diamond, Michael

Drug resistance mutations and viral load in human immunodeficiency virus type 2 and dual HIV-1/HIV-2 infected patients in Ghana

加纳2型人类免疫缺陷病毒和HIV-1/HIV-2双重感染患者的耐药突变和病毒载量

Abana, Christopher Z; Sagoe, Kwamena W C; Bonney, Evelyn Y; Maina, Edward K; Aziati, Ishmael D; Agbosu, Esinam; Mawuli, Gifty; Styer, Linda M; Ishikawa, Koichi; Brandful, James A M; Ampofo, William K